Form 4 for KURA Kura Oncology, Inc.
Accepted 2026-05-22 16:05:07 ET · period of report 2026-05-21 · accession 0001193125-26-236838 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-22 16:05 | 2026-05-21 | KURA | Powl Brian T. | Chief Commercial Off | S - Sale | $11.00 | -10.0K | 173.6K | -5% | -$110.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | S | D | 10,000 | $11.00 | 173,614 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. |